This offering credibly makes frontline WGS a reality by decreasing costs and increasing scale to match simpler tests. Combined with quality associated with Broad Clinical labs and Fabric Genomics, this presents an unparalleled solution and value for clinicians and researcher alike.
Launching and Scaling NGS Testing for Diagnostics or Risk Screening
Is your Clinical Lab Considering Launching NGS Testing for Hereditary Cancer?
A Seamless End-to-End Clinical NGS Analysis Solution, Fully Integrated with Fabric Enterprise
Francisco M. De La Vega, et al, Fabric Genomics
Francisco M. De La Vega, et al, Fabric Genomics
Melanie Babcock, et al, Fabric Genomics
Francisco M. De La Vega, et al, Fabric Genomics
Francisco M. De La Vega, et al, Fabric Genomics
Ritu Kamal, et al, Fabric Genomics
S. Niranjan Shekar, Ph.D. et al, Fabric Genomics
Ranomics - Toronto, Cananda
Anthony Fejes, Ph.D. et al, Fabric Genomics
Anna Lewis, Ph.D. et al, Fabric Genomics
Melanie Babcock, Ph.D. et al, Fabric Genomics
Wenjie Chen, Ph.D. et al, LabCorp – Integrated Genetics
Amber Hildreth, D.O. et al, Rady Children’s Institute for Genomic Medicine
John Phillips III, M.D. et al, Vanderbilt University Medical Center & UDN
